Stock & Company Details
CytoMed Therapeutics Ltd $GDTC
Price:
N/A
N/A
12M
$11M
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.69
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
GDTC technical indicators
Latest CytoMed Therapeutics Ltd (GDTC) indicator readings as of 2026-08-28.
GDTC's 14-day RSI is 48.9, in neutral territory. At $0.92 it is trading 19.6% below its 200-day moving average of $1.14, and below its 50-day average of $0.95. Price sits in the middle of its Bollinger Bands ($0.76 to $1.03). ADX reads 21.0, sitting between trending and range-bound.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is majority revenue generator.
Finance Bot
Ask your questions
Start by typing a question below.
